Naturalistic Prospective Non-interventional Study on Rheumatoid Arthritis (RA) Patients Treated With Rituximab According to Local Treatment Guidelines.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 20 Aug 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 01 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.